Диссертация (Разработка инъекционных лекарственных форм цифетрилина), страница 23
Описание файла
Файл "Диссертация" внутри архива находится в папке "Разработка инъекционных лекарственных форм цифетрилина". PDF-файл из архива "Разработка инъекционных лекарственных форм цифетрилина", который расположен в категории "". Всё это находится в предмете "фармацевтика" из Аспирантура и докторантура, которые можно найти в файловом архиве МГМУ им. Сеченова. Не смотря на прямую связь этого архива с МГМУ им. Сеченова, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата фармацевтических наук.
Просмотр PDF-файла онлайн
Текст 23 страницы из PDF
, Li S.，et al . Study on the effect of somatostatin inreversing the drug resistance of cystis cell line.// Chinese Journal ofSurgery , 2008, 46(5): P.381-383.Ram I.M., Ajit S.N., Laura T. et al. Emerging trends in oral delivery ofpeptide and protein drugs.// Crit Rev Ther Drug Carrier Syst. 2003.Vol.20. P.153-214.Reardon DB, Dent P, Wood SL, et al. Activation in vitro of somatostatinreceptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphataseactivity in membranes from transfected Ras-tran sformed NIH3T3 cells:coexpression with catalytically inactive SHP-2 blocks responsiveness.// J.Mol Endocrinol, 1997, 11(8): P.1062-1069.Redding T.W., Schally A.V.
Inhibition of growth of pancreaticcarcinomas in animal models by analogs of hypothalamic hormonts.//Proc.Natl. Acad.Sci. USA. 1984. Vol. 81. P.248-252 .Reubi J.C. A somatostatin analog inhibits hondrosarcoma and insulinomatumour growth.// Acta Endocrinologica. 1985. Vol. 109. P.108-114.Richardson E.S., Pitt W.G., Woodbury D.J.
The role of Cavitation inLiposome Formation // Biophysical J. – December 2007. Vol.93, № 12 P.4100-4107.103.RJ Lee ， PS Low . Delivery of liposomes into cultured KB cells via104.folate receptor-mediated endocytosis.// J Biol Chem. 1994 Feb4;269(5):P.3198.Rosskopf D., Schurks M., Manthey I. et al. Signal transduction ofsomatostatin in human B lymphoblasts.// Am J Physiol Cell Physiol. 2003.Vol.
284. P.179–190.142105.106.107.108.109.110.111.112.113.114.115.116.117.Sakurabayashi S, Koh K C, Chen L, Groszmann R J. Octreotideameliorates the increase in colateral blood flow during post prandialhyperemia in portal hypertensive rats.// J Hepatol, 2002, 36:P.507-512.Sas D A, Chopra K B. Portal hypertension and variceal hemorrhage.//Med Clin North Am, 2009, 93:P.837-853.Scambia G., Panici P.B., Baijcchi G. et al. Antiproliferative effects ofsomatostatin and of the somatostatin analog SMS 201-995 on three humanbreast cancer cell lines.//J.
Cancer Res. Clin. Oncology. 1988. Vol. 106.P.416-422.Schally A.V. Oncological applications of somatostatin analogs.// CancerResearch. 1988. Vol. 48, P.6977-6985.Schally A.V., Comary-Schally A.M., Nagy A. et. al. Hypothalamichormones and cancer.// Front. Neuroendocrinol. 2001. Vol. 22. P.248-291.Sereemaspun A, Rojanathanes R, Wiwanitkit V. Effect of GoldNanoparticle on Renal Cell: An Implication for Exposure Risk// J. RenalFailure, 2008, 30(3):P.323-325.Sharma K, Patel YC, Srikant CB. C-terminal region of humansomatostatin receptor 5 is required for induction of Rb and G1 cell cyclearrest.// J.
Mol Endocrinol, 1999, 13(1): P.82-90.Setyono-Han B., Henkelman M.S., Foekens J.A. et al. Direct inhibitoryeffects of somatostatin (analogues) on the growth of human breast cancercells./Cancer Res. 1987. Vol. 47. P.1566-1570.Sheridan M.A., Kittilson J.D., Ehrman M.M. et al. “Polygenic expressionof somatostatin in rainbow trout” in Kawashima S, Kikuyama S (eds.)Advances in comparative endocrinology. 1997. P.291-294Silva R., Ferreira H., Little C. et al.
Effect of ultrasound parameters forunilamellar liposome preparation // Ultrasonics Sonochemistry. – 2010. –Vol. 17, № 3. – P. 628-632.Singh P., Townsend C.M. A long action somatostatin analog (SRIF) (201995) and proglumide (PGL) inhibit the trophic and gastrin receptor (GR)regulatory effects of pentagastrin (PG) on mouse colon cancer (MC-26)cells in vivo./Gastroenterology. 1986.
Vol. 90. P.1636.Singh P., Townsend C.M. A long action somatostatin analog (SRIF) (201995) and proglumide (PGL) inhibit the trophic and gastrin receptor (GR)regulatory effects of pentagastrin (PG) on mouse colon cancer (MC-26)cells in vivo./Gastroenterology. 1986. Vol. 90. P.1636Smirnova L.I., Smirnova A.P., Ustinkina S.V.
et al. Synthesis andantitumor activity of modified somatostatin analogues./ Journal of Peptide143118.119.120.121.122.123.124.125.126.127.128.Science 3rd International and 28th European Peptide Symposium,September 5-10, 2004, Prague, Czech Rebublic, p.261Smirnova L.I., Smirnova A.P., Ustinkina S.V. et al. Synthesis andantitumour activity of modified somatostatin analogues. //Peptides 2004Proceeding of the Third International and Twenty-Eighth EuropeanPeptide Symposium, September 5-10, 2004. – Prague, Crech Republic,P.946-947.Smith J.P., Solomon T.E.
Effects of gastrin, proglumide and somatostatinon growth of human colon cancer./ /Gastroenterology. 1988. Vol. 95.:P.1541-1548.Songgang L, Jiyu L, Gongwei, et al. Somatostatin enhances thechemosensitivity of GBC-SD cell line to doxorubicin through arrestingthe cell cycle to Sphase rather than through the P53/ Bax-dependedapoptosis way in vitro.// J. Hepatogastroenterology, 2009, 56(95): P.12531260.Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs ingastroenteropancreatic neuroendocrine tumors.// World J Gastroenterol,2010:28, 16(24):P.2963-2970.Srikant CB, Shen SH.
Octapeptide somatostatin analog SMS 201-995induces translocation of intracellular PTP1C to membranes in MCF-7human breast adenocarcinoma cells.//J. Endocrinology, 1996, 137(8):P.3461-3468.Sułkowski W.W., Pentak D., Nowak K. et al. The influence oftemperature, cholesterol content and pH on liposome stability // J.
Mol.Struct. 2005. Vol. 744–747. – P. 737-747.Sun P.，Hu J.，Lin W. , et al . The effects of preoperative regionalarterial perfusion growth inhibition and chemotherapy drugs onproliferating apoptosis and vascular formation in colon cancer cells.//Journal of Modern Oncology , 2007, 15(2):P. 222-224.Sun W.Q., Leopold A.C., Crowe L.M. et al. Stability of dry liposomes insugar glasses // Biophys. J. – 1996.
– Vol. 70, № 4. – P. 1769-1776.Susini C., Buscail L. Rationale for the use of somatostatin analogs asantitumour agents.//Annals of Oncology. 2006. Vol. 17/12.P. 1733-1742.Tang X, Takekoshi S, Itoh J, et al. Somatostatin analogue inhibits themobility of prostate carcinoma cells: a new therapeutic method foradvanced prostate carcinoma.//J. Int J Oncol, 2010, 37(5):P. 1077-1083.Tao Chen -A Lewis S. Choi,B Susan Einstein,B Matthew A. Klippenstein,Peter Scherrer And Pieter R. Cuuisqb. Proton-induced permeability and144129.130.131.132.133.134.135.136.137.138.139.140.fusion of large unilamellar vesicles by covalently conjugated poly(2ethylacrylic acid). // Journal of liposome research, 1999,9(3), P.387-405Thangaraju M , Shanua K, Liu D, et al. In terdependent regulation ofintracellular acidification and SHP-1 in apoptosis[J].
Cancer Res, 1999,59(7): P.1649-1654.Theodoropoulou M, Zhang J, Laupheimer S, et al. Octreotide, asomatostatin analogue, mediates its antiproliferative action in pituitarytumor cells by altering phosphatidylinositol 3-kinase signaling andinducing zac1 expression// J. Cancer Res, 2006, 66(3): P.1576-1582.Tom assetti P, Migliori M, Caleti G C, etal. Treatment of type II gastriccarcinoid tumors with somatostatin analogues.
// N Engl J Med,2000.343:P.551-554.Torchilin V. Recent advances with liposomes as pharmaceutical carriers //Nat. Rev. Drug Discov. – 2005. – Vol. 4, № 2. – P. 145-160.Tsinontides S.C., Rajniak P., Hunke W.A. et al. Freeze drying principlesand practice for successful scale-up to manufacturing // InternationalJournal of Pharmaceutics. – 2004. – Vol. 280, № 1-2. – P. 1-16.Upp J.R., Olson D., Poston G.J. et al.
Inhibition of growth of two humanpancreatic adenocarcinomas by somatostatin and analog SMS 201-995./Am. J. Surgery. 1988. Vol. 155. P.29-35 .Vale W., Brazeau P., Rivier C. et al. Somatostatin.//Rec. Prog. HormoneRes. 1975. Vol. 31.P. 365-397.Voinea M, Simionescu M. Designing of 'intelligent' liposomes forefficient delivery of drugs.// J Cell Mol Med. 2002 Oct-Dec;6(4):P.465-74.Wagner A., Vorauer-Uhl K. Liposome technology for Industrial Purposes// Journal of Drug Delivery.
– 2011. – Vol. 2011, № 2011[Электронныйресурс]. – URL:http://www.hindawi.com/archive/2011/591325.Woeste G, Wullstein C, Meyer S, et al. Octreotide attenuates impairedmicrocirculation in postischemic pancreatitis when administered beforeinduction of ischemia.//J. Transplantation, 2008, 86(7):P.961-967.Xiping Z , Jie Z, Qin X, et al. In fluence of baicalin and octreotide on NFkappa Band p-select in expression in liver and kidney of rats with severeacute pancreatitis.// Inflammation, 2009, 32:P.1-11.Yamaguchi M, Yamada Y, Hosokawa Y, et al.
Long-term suppressiveeffect of octreotide on pro gression of metastatic gastrinoma with multipleendocrine neoplasia type 1: seven-year follow up.//J. Intern Med, 2010,49(15): P.1557-1563.145141.142.143.Yamaguchi T., Nomura M., Matsuoka T. et al. Effect of frequency andpower of ultrasound on the size reduction of liposome // Chemistry andPhysics of Lipids.
